+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Radiotherapy Market by Type, Brachytherapy, Product, Application, End User - Forecasts to 2023

  • ID: 4745162
  • Report
  • 227 Pages
  • Markets and Markets
1 of 5
The Global Radiotherapy Market is Projected to reach USD 6.8 Billion by 2023 from USD 5.6 Billion in 2018, at a CAGR of 4.1%.

FEATURED COMPANIES

  • Accuray Incorporated
  • C.R.Bard, Inc.
  • Elekta
  • Hitachi, Ltd.
  • Ion Beam Applications SA
  • Isoray Medical, Inc.
  • MORE

Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT, Stereotactic), Brachytherapy (LDR, HDR)), Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Application (Prostate, Breast), End User (Hospital) - Forecasts to 2023

The radiotherapy market is projected to grow at a CAGR of 4.1% during the forecast period

The global radiotherapy market is projected to reach USD 6.8 billion by 2023 from USD 5.6 billion in 2018, at a CAGR of 4.1%. Growth in this market is largely driven by factors such as the growing global prevalence of cancer, increasing adoption of radiotherapy in clinical trials, and the increasing number of radiotherapy centers worldwide. However, the underdeveloped public health infrastructure in emerging countries, shortage of trained and skilled radiation oncologists, and the limited access to and affordability of various radiotherapy treatment options are the major factors that are expected to restrain the growth of this market during the forecast period.

The linear accelerators segment is expected to account for the largest market share during the forecast period

Based on product type, the external beam radiotherapy products market is segmented into linear accelerators (LINAC), particle therapy systems, and conventional cobalt-60 teletherapy units. The linear accelerators segment is expected to account for the largest share of this market in 2018, driven by the development of advanced systems and their growing adoption across the globe.

The seeds segment is expected to hold the largest share of the internal beam radiotherapy/brachytherapy products market during the forecast period

Based on product type, the internal beam radiotherapy/brachytherapy products market is segmented into seeds, applicators, afterloaders, and electronic brachytherapy products. The seeds segment is expected to account for the largest share of this market in 2018. The large share of this segment can be attributed to the growing availability of seeds; advances in patient selection, treatment planning, technique, and technology; and growing applications in prostate cancer treatment.

Europe to account for the second-largest share of the global market in 2018

The radiotherapy market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. Europe is expected to account for the second-largest share of the global radiotherapy market in 2018. The growing incidence of cancer, supportive government initiatives, and the implementation of radiotherapy training programs & conferences/symposiums are the major factors propelling the demand for radiotherapy products in Europe. Furthermore, several key market players are focusing on enhancing their radiotherapy products to improve the quality of patient care across Europe.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (25%), Tier 2 (30%), and Tier 3 (45%)
  • By Designation: C-level (26%), Director-level (30%), and Others (44%)
  • By Region: North America (35%), Europe (26%), APAC (23%), and RoW (16%)

The major players in the market include Varian Medical Systems, Inc. (US), Elekta AB (Sweden), Accuray Incorporated (US), Ion Beam Applications SA (Belgium), ViewRay, Inc. (US), IsoRay Medical, Inc. (US), Hitachi Ltd. (Japan), Panacea Medical Technologies Pvt. Ltd. (India), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc (US), P-cure Ltd. (Israel), Theragenics Corporation (US), and C.R.Bard, Inc. (US), among others.

Research Coverage
This report studies the radiotherapy market based on type, product type, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the radiotherapy market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Accuray Incorporated
  • C.R.Bard, Inc.
  • Elekta
  • Hitachi, Ltd.
  • Ion Beam Applications SA
  • Isoray Medical, Inc.
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Limitations and Assumptions
2.4.1 Limitations
2.4.2 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Radiotherapy Market Overview
4.2 Europe: External Radiotherapy Market, By Type, 2018
4.3 Internal Beam Radiotherapy/Brachytherapy Market, By Product Type
4.4 External Beam Radiotherapy Market, By Application
4.5 Regional Analysis: Radiotherapy Market, By End User
4.6 Radiotherapy Market, By Country

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Technological Advancements
5.2.1.2 Rising Prevalence of Cancer
5.2.1.3 Increasing Number of Conferences and Symposia Focusing on Spreading Awareness About the Benefits of Radiotherapy
5.2.1.4 Growing Use of Particle Therapy for Cancer Treatment
5.2.2 Restraints
5.2.2.1 Lack of Adequate Healthcare Infrastructure
5.2.2.2 Shortage of Trained Personnel
5.2.2.3 Affordability and Accessibility of Treatment
5.2.2.4 Complex Nature of Radiotherapy
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Growing Government and Private Investments to Meet the Increasing Demand for Cancer Treatment
5.2.3.3 Improving Reimbursement Scenario
5.2.4 Challenges
5.2.4.1 Difficulties in Visualizing Tumors During Radiotherapy Procedures
5.2.4.2 Risk of Radiation Exposure
5.3 Industry Trends
5.3.1 Growing Adoption of Pencil-Beam Scanning
5.3.2 Growing Number of Collaborations and Acquisitions

6 Radiotherapy Market, By Product Type
6.1 Introduction
6.2 External Beam Radiotherapy
6.2.1 Linear Accelerators
6.2.1.1 Conventional Linear Accelerators
6.2.1.1.1 Lower Equipment and Maintenance Cost Will Drive the Market for Conventional Linacs
6.2.1.2 Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
6.2.1.2.1 Automation and Real-Time Tracking Features Have Ensured Demand for Stereotactic Advanced Linac
6.2.1.2.2 Gamma Knife
6.2.1.2.2.1 The Gamma Knife System is Considered A Gold Standard for Brain Tumor Treatment
6.2.1.2.3 Cyberknife
6.2.1.2.3.1 Cyberknife Offers A Precise Radiation Delivery Method With Specialized Tracking and Robotic Correction Capabilities
6.2.1.2.4 Tomotherapy
6.2.1.2.4.1 360-Degree (Helical) Radiation Treatment With Tomotherapy is Adding Growth Opportunities to This Segment
6.2.2 Particle Therapy Systems
6.2.2.1 Cyclotrons
6.2.2.1.1 Leading Players in the Particle Therapy Market Mainly Manufacture Cyclotrons
6.2.2.2 Synchrotrons
6.2.2.2.1 Increasing Investment for the Development of Synchrotron Facilities are Contributing to Market Growth
6.2.2.3 Synchrocyclotrons
6.2.2.3.1 High Space Requirements of Synchrocyclotrons are Limiting Its Widespread Adoption
6.2.3 Conventional Cobalt-60 Teletherapy Units
6.2.3.1 High Cost and Risk of Radiation Exposure With Cobalt-60 Radioisotopes Have Hindered the Growth of This Segment
6.3 Internal Beam Radiotherapy/Brachytherapy
6.3.1 Seeds
6.3.1.1 Adverse Side-Effects Associated With Seeds Limit Their Adoption
6.3.2 Applicators
6.3.2.1 Manual Applicators Pose A High Risk of Radiation Exposure to the Patients and Staff
6.3.3 Afterloaders
6.3.3.1 Modern Afterloaders Offer Proper Positioning and Better Control of Isotopes Inside the Patient Body
6.3.4 Electronic Brachytherapy Products
6.3.4.1 Electronic Brachytherapy Requires Low Amount of Shielding Than Alternatives
6.4 Systemic Radiotherapy
6.4.1 Iobenguane (I-131)
6.4.1.1 Increasing Incidence of Thyroid Cancer is Driving the Growth of This Segment
6.4.2 Samarium-153
6.4.2.1 Samarium-153 has Wide Applications for Bone Metastasis
6.4.3 Rhenium-186
6.4.3.1 Lack of Insurance Coverage With the Use of Rhenium-186 Restricting Its Growth
6.4.4 Other Systemic Radiotherapy Products

7 Radiotherapy Market, By Type
7.1 Introduction
7.2 External Beam Radiotherapy
7.2.1 Image-Guided Radiotherapy
7.2.1.1 Image-Guided Radiotherapy is Widely Used to the Treatment of Deep-Seated Tumors
7.2.2 3d Conformal Radiotherapy
7.2.2.1 Multiple Beams With 3d-Crt Allow Precise Radiation Conforming to the Tumor Size and Shape
7.2.3 Intensity-Modulated Radiotherapy
7.2.3.1 Volumetric Arc Therapy
7.2.3.1.1 Advancements in the Vmat Technology Driving Its Widespread Adoption
7.2.3.2 Tomotherapy
7.2.3.2.1 Minimal Exposure to Normal Tissues – A Major Advantage of Tomotherapy
7.2.4 Stereotactic Therapy
7.2.4.1 Stereotactic Therapy Offers A Minimally Invasive Alternative to Ablation Surgeries
7.2.5 Particle Therapy
7.2.5.1 Particle Therapy is Increasingly Being Adopted as A Primary Mode of Treatment for Various Cancer Types
7.3 Internal Beam Radiotherapy
7.3.1 Low-Dose-Rate Brachytherapy
7.3.1.1 Lower Risk of Radiation Exposure to the Surrounding Tissues With Ldr Supporting Market Growth
7.3.2 High-Dose-Rate Brachytherapy
7.3.2.1 Better Patient Care With HDR is Driving Its Widespread Adoption
7.3.3 Pulsed-Dose-Rate Brachytherapy
7.3.3.1 Pulsed-Dose Rate Brachytherapy Combines the Advantages of HDR and Ldr Brachytherapy
7.4 Systemic Radiotherapy
7.4.1 Intravenous Radiotherapy
7.4.1.1 Intravenous Route of Brachytherapy Results in Maximum Bioavailability
7.4.2 Oral Radiotherapy
7.4.2.1 Longer Distribution Time Associated With the Oral Mode of Radiation Delivery Limiting Its Demand
7.4.3 Instillation Radiotherapy
7.4.3.1 Lesser Localization With Instillation Brachytherapy is Limiting Its Widespread Adoption

8 Radiotherapy Market, By Application
8.1 Introduction
8.2 External Beam Radiation Therapy
8.2.1 Prostate Cancer
8.2.1.1 High Incidence of Prostate Cancer Will Drive the Demand for Ebrt
8.2.2 Breast Cancer
8.2.2.1 Adoption of Advanced Ebrt Systems and Increasing Research Will Drive Market Growth
8.2.3 Lung Cancer
8.2.3.1 Radiotherapy Can Be Used as Solo Or Combination Therapy for Lung Cancer
8.2.4 Head and Neck Cancer
8.2.4.1 Benefits of External Radiotherapy Will Support Its Use in Head and Neck Cancer Treatment
8.2.5 Colorectal Cancer
8.2.5.1 Availability of Alternative Therapeutic Options Limits the Growth of This Segment
8.2.6 Other Cancers
8.3 Internal Beam Radiotherapy/Brachytherapy
8.3.1 Prostate Cancer
8.3.1.1 Rapidity and Precision of Brachytherapy in Prostate Cancer Treatment Have Driven Market Growth
8.3.2 Gynecological Cancer
8.3.2.1 Availability of Alternatives Hinders the Adoption of Brachytherapy in Gynecological Cancer Treatment
8.3.3 Breast Cancer
8.3.3.1 Precision and Rapid Treatment Times are Driving the Use of Brachytherapy in Breast Cancer Applications
8.3.4 Cervical Cancer
8.3.4.1 A Combination of Brachytherapy and Chemotherapy is Typically Used for Cervical Cancer Treatment
8.3.5 Penile Cancer
8.3.5.1 Advantages of Brachytherapy in Penile Cancer Treatment Have Driven Its Adoption
8.3.6 Other Cancers

9 Radiotherapy Market, By End User
9.1 Introduction
9.1.1 Hospitals
9.1.1.1 Increasing Number of Small-Footprint Advanced Radiotherapy Products Promoting Their Adoption in Hospitals
9.1.2 Independent Radiotherapy Centers
9.1.2.1 Rising Consolidation of Healthcare Networks is Challenging the Growth of Freestanding Radiotherapy Centers

10 Radiotherapy Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Growing Government Initiatives Boosting the Adoption of Radiotherapy in the Us
10.2.2 Canada
10.2.2.1 Rising Cancer Incidence Driving the Demand for Radiotherapy in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Increasing Awareness of Novel and Advanced Radiotherapy Products A Key Factor Contributing to Market Growth
10.3.2 France
10.3.2.1 Growing Government Initiatives Boosting the Adoption of Radiotherapy in France
10.3.3 UK
10.3.3.1 Leading Market Players Focusing on Expanding Their Product Offerings in the Uk
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Presence of A Large Number of Local Manufactures Supporting the Growth of the Radiotherapy Market in China
10.4.2 Japan
10.4.2.1 Rising Prevalence of Cancer is Driving the Adoption of Radiotherapy in Japan
10.4.3 India
10.4.3.1 Shortage of Skilled Radiotherapy Professionals in India is Restraining Market Growth
10.4.4 Rest of Asia Pacific
10.5 Rest of the World

11 Competitive Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Competitive Scenario
11.3.1 Product Launches and Approvals
11.3.2 Acquisitions
11.3.3 Expansions
11.3.4 Partnerships, Agreements, and Collaborations
11.4 Vendor Dive Overview
11.5 Vendor Inclusion Criteria
11.6 Vendor Dive
11.6.1 Vanguards
11.6.2 Innovators
11.6.3 Dynamic Players
11.6.4 Emerging Companies

12 Company Profiles
12.1 Accuray Incorporated
12.2 C. R. Bard, Inc.
12.3 Elekta
12.4 Hitachi, Ltd.
12.5 IBA (Ion Beam Applications Sa)
12.6 Isoray Medical, Inc.
12.7 Mevion Medical Systems, Inc.
12.8 Optivus Proton Therapy, Inc.
12.9 Panacea Medical Technologies Pvt. Ltd.
12.10 P-Cure Ltd.
12.11 Provision Healthcare, LLC.
12.12 Sumitomo Heavy Industries, Ltd
12.13 Theragenics Corporation
12.14 Varian Medical Systems, Inc.
12.15 Viewray Inc.

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

List of Tables
Table 1 National Average Medicare Reimbursement: Outpatient Prospective Payment System (Opps) Estimated Per Course
Table 2 Radiotherapy Market, By Product Type, 2016–2023 (USD Million)
Table 3 External Beam Radiotherapy Market, By Product Type, 2016–2023 (USD Million)
Table 4 External Beam Radiotherapy Market, By Region, 2016–2023 (USD Million)
Table 5 External Beam Radiotherapy Market for Linear Accelerators, By Type, 2016–2023 (USD Million)
Table 6 External Beam Radiotherapy Market for Linear Accelerators, By Region, 2016–2023 (USD Million)
Table 7 Conventional Linear Accelerators Market, By Region, 2016–2023 (USD Million)
Table 8 Stereotactic Advanced Electron/Cobalt-60 Linac Market, By Product Type, 2016–2023 (USD Million)
Table 9 Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators Market, By Region, 2016–2023 (USD Million)
Table 10 Gamma Knife Market, By Region, 2016–2023 (USD Million)
Table 11 Cyberknife Market, By Region, 2016–2023 (USD Million)
Table 12 Tomotherapy Market, By Region, 2016–2023 (USD Million)
Table 13 External Beam Radiotherapy Market for Particle Therapy Systems, By Product Type, 2016–2023 (USD Million)
Table 14 External Beam Radiotherapy Market for Particle Therapy Systems, By Region, 2016–2023 (USD Million)
Table 15 Particle Therapy Systems Market for Cyclotrons, By Region, 2016–2023 (USD Million)
Table 16 Particle Therapy Systems Market for Synchrotrons, By Region, 2016–2023 (USD Million)
Table 17 Particle Therapy Systems Market for Synchrocyclotrons, By Region, 2016–2023 (USD Million)
Table 18 External Beam Radiotherapy Market for Conventional Cobalt-60 Teletherapy Units, By Region, 2016–2023 (USD Million)
Table 19 Internal Beam Radiotherapy/Brachytherapy Market, By Product Type, 2016–2023 (USD Million)
Table 20 Internal Beam Radiotherapy/Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 21 Internal Beam Radiotherapy/Brachytherapy Market for Seeds, By Region, 2016–2023 (USD Million)
Table 22 Internal Beam Radiotherapy/Brachytherapy Market for Applicators, By Region, 2016–2023 (USD Million)
Table 23 Internal Beam Radiotherapy/Brachytherapy Market for Afterloaders, By Region, 2016–2023 (USD Million)
Table 24 Internal Beam Radiotherapy/Brachytherapy Market for Electronic Brachytherapy Products, By Region, 2016–2023 (USD Million)
Table 25 Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 26 External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 27 External Beam Radiotherapy Market, By Region, 2016–2023 (USD Million)
Table 28 Image-Guided Radiotherapy Market, By Region, 2016–2023 (USD Million)
Table 29 3d Conformal Radiotherapy Market, By Region, 2016–2023 (USD Million)
Table 30 Intensity-Modulated Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 31 Intensity-Modulated Radiotherapy Market, By Region, 2016–2023 (USD Million)
Table 32 Volumetric Arc Therapy Market, By Region, 2016–2023 (USD Million)
Table 33 Tomotherapy Market, By Region, 2016–2023 (USD Million)
Table 34 Stereotactic Therapy Market, By Region, 2016–2023 (USD Million)
Table 35 Particle Therapy Market, By Region, 2016–2023 (USD Million)
Table 36 Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 37 Internal Beam Radiotherapy/Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 38 Low-Dose-Rate Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 39 High-Dose-Rate Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 40 Pulsed-Dose-Rate Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 41 Radiotherapy Applications Market, By Type, 2016-2023 (USD Million)
Table 42 External Beam Radiotherapy Applications Market, By Type, 2016-2023 (USD Million)
Table 43 External Beam Radiotherapy Applications Market for Prostate Cancer, By Region, 2016-2023 (USD Million)
Table 44 External Beam Radiotherapy Applications Market for Breast Cancer, By Region, 2016-2023 (USD Million)
Table 45 External Beam Radiotherapy Applications Market for Lung Cancer, By Region, 2016-2023 (USD Million)
Table 46 External Beam Radiotherapy Applications Market for Head and Neck Cancer, By Region, 2016-2023 (USD Million)
Table 47 External Beam Radiotherapy Applications Market for Colorectal Cancer, By Region, 2016-2023 (USD Million)
Table 48 External Beam Radiotherapy Applications Market for Other Cancers, By Region, 2016-2023 (USD Million)
Table 49 Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016-2023 (USD Million)
Table 50 Internal Beam Radiotherapy/Brachytherapy Applications Market for Prostate Cancer, By Region, 2016-2023 (USD Million)
Table 51 Internal Beam Radiotherapy/Brachytherapy Applications Market for Gynecological Cancer, By Region, 2016-2023 (USD Million)
Table 52 Internal Beam Radiotherapy/Brachytherapy Applications Market for Breast Cancer, By Region, 2016-2023 (USD Million)
Table 53 Internal Beam Radiotherapy/Brachytherapy Applications Market for Cervical Cancer, By Region, 2016-2023 (USD Million)
Table 54 Internal Beam Radiotherapy/Brachytherapy Applications Market for Penile Cancer, By Region, 2016-2023 (USD Million)
Table 55 Internal Beam Radiotherapy/Brachytherapy Applications Market for Other Cancers, By Region, 2016-2023 (USD Million)
Table 56 Radiotherapy Market, By End User, 2016–2023 (USD Million)
Table 57 Radiotherapy Market for Hospitals, By Region, 2016–2023 (USD Million)
Table 58 Radiotherapy Market for Independent Radiotherapy Centers, By Region, 2016–2023 (USD Million)
Table 59 Radiotherapy Market, By Region, 2016–2023 (USD Million)
Table 60 North America: Radiotherapy Market, By Country, 2016–2023 (USD Million)
Table 61 North America: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 62 North America: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 63 North America: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 64 North America: Stereotactic Advanced Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 65 North America: Particle Therapy Systems Market, By Type, 2016–2023 (USD Million)
Table 66 North America: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 67 North America: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 68 North America: Intensity-Modulated Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 69 North America: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 70 North America: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 71 North America: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 72 North America: Radiotherapy Market, By End User, 2016–2023 (USD Million)
Table 73 US: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 74 US: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 75 US: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 76 US: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 77 Canada: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 78 Canada: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 79 Canada: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 80 Canada: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 81 Europe: Radiotherapy Market, By Country, 2016–2023 (USD Million)
Table 82 Europe: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 83 Europe: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 84 Europe: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 85 Europe: Stereotactic Advanced Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 86 Europe: Particle Therapy Systems Market, By Type, 2016–2023 (USD Million)
Table 87 Europe: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 88 Europe: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 89 Europe: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 90 Europe: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 91 Europe: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 92 Europe: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 93 Europe: Radiotherapy Market, By End User, 2016–2023 (USD Million)
Table 94 Germany: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 95 Germany: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 96 Germany: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 97 Germany: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 98 France: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 99 France: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 100 France: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 101 France: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 102 UK: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 103 UK: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 104 UK: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 105 UK: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 106 Rest of Europe: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 107 Rest of Europe: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 108 Rest of Europe: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 109 Rest of Europe: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 110 Asia Pacific: Radiotherapy Market, By Country, 2016–2023 (USD Million)
Table 111 Asia Pacific: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 112 Asia Pacific: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 113 Asia Pacific: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 114 Asia Pacific: Stereotactic Advanced Linear Accelerators Market, By Product, 2016–2023 (USD Million)
Table 115 Asia Pacific: Particle Therapy Systems Market, By Product, 2016–2023 (USD Million)
Table 116 Asia Pacific: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 117 Asia Pacific: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 118 APAC: Intensity-Modulated Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 119 Asia Pacific: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 120 Asia Pacific: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 121 Asia Pacific: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 122 Asia Pacific: Radiotherapy Market, By End User, 2016–2023 (USD Million)
Table 123 China: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 124 China: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 125 China: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 126 China: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 127 Japan: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 128 Japan: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 129 Japan: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 130 Japan: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 131 India: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 132 India: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 133 India: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 134 India: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 135 RoAPAC: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 136 RoAPAC: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 137 RoAPAC: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 138 RoAPAC: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 139 RoW: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 140 RoW: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 141 RoW: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 142 RoW: Stereotactic Advanced Linear Accelerators Market, By Product, 2016–2023 (USD Million)
Table 143 RoW: Particle Therapy Systems Market, By Product, 2016–2023 (USD Million)
Table 144 RoW: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 145 RoW: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 146 RoW: Intensity-Modulated Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 147 RoW: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 148 RoW: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 149 RoW: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 150 RoW: Radiotherapy Market, By End User, 2016–2023 (USD Million)

List of Figures
Figure 1 Radiotherapy Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primaries: Global Radiotherapy Market
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Market Size Estimation: Bottom-Up Approach
Figure 6 Market Size Estimation: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Radiotherapy Market, By Type, 2018 (USD Million)
Figure 9 External Beam Radiotherapy Market, By Product Type, 2018 vs 2023 (USD Million)
Figure 10 Internal Beam Radiotherapy Market, By Product Type, 2018 vs 2023 (USD Million)
Figure 11 External Beam Radiotherapy Market Share, By Application, 2018 vs 2023
Figure 12 Radiotherapy Market, By End User, 2018 vs 2023 (USD Million)
Figure 13 Radiotherapy Market: Geographical Snapshot
Figure 14 Rising Cancer Prevalence Across the Globe is Driving Growth in the Radiotherapy Market
Figure 15 Image-Guided Radiotherapy to Dominate the External Beam Radiotherapy Market in Europe in 2018
Figure 16 Afterloaders to Register the Highest CAGR in the Market During the Forecast Period
Figure 17 Others Cancer Application Segment to Grow at the Fastest Rate in the External Beam Radiotherapy Market During the Forecast Period
Figure 18 North America to Dominate the Radiotherapy End User Market in 2018
Figure 19 China to Register the Highest CAGR During the Forecast Period (2018–2023)
Figure 20 Radiotherapy Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Incidence of Cancer, By Region, 2012–2020 (Thousand)
Figure 22 Particle Therapy Systems to Register Highest Growth in the External Beam Radiotherapy Market During the Forecast Period
Figure 23 Seeds to Dominate Internal Beam Radiotherapy Market During the Forecast Period
Figure 24 Image-Guided Radiotherapy Segment to Account for the Largest Share of the External Beam Radiotherapy Market in 2018
Figure 25 Number of Particle Therapy Facilities Present (As of October 2018) & Under Construction Across the Globe
Figure 26 High-Dose-Rate Brachytherapy Segment is Expected to Account for the Largest Share of the Internal Beam Radiotherapy Market in 2018
Figure 27 Prostate Cancer to Dominate the External Beam Radiotherapy Applications Market During the Forecast Period
Figure 28 Breast Cancer to Register Highest Growth in Internal Beam Radiotherapy/Brachytherapy Applications Market
Figure 29 Hospitals Segment to Grow at the Highest CAGR During the Forecast Period
Figure 30 North America: Radiotherapy Market Snapshot
Figure 31 Europe: Radiotherapy Market Snapshot
Figure 32 Asia Pacific: Radiotherapy Market Snapshot
Figure 33 RoW: Radiotherapy Market Snapshot
Figure 34 Key Developments in the Radiotherapy Market Between 2015–2018
Figure 35 Radiotherapy Market Share, By Key Player, 2017
Figure 36 Competitive Leadership Mapping (Overall Market)
Figure 37 Competitive Leadership Mapping (SME/Start-Ups)
Figure 38 Accuray Incorporated: Company Snapshot (2018)
Figure 39 C. R. Bard, Inc.: Company Snapshot (2016)
Figure 40 Elekta Ab: Company Snapshot (2017)
Figure 41 Hitachi: Company Snapshot (2017)
Figure 42 Ion Beam Applications Sa: Company Snapshot (2017)
Figure 43 Isoray Medical, Inc.: Company Snapshot (2018)
Figure 44 Sumitomo Heavy Industries: Company Snapshot (2016)
Figure 45 Varian Medical Systems, Inc.: Company Snapshot (2018)
Figure 46 Viewray, Inc.: Company Snapshot (2017)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
5 of 5
  • Accuray Incorporated
  • C.R.Bard, Inc.
  • Elekta
  • Hitachi, Ltd.
  • IBA (Ion Beam Applications Sa)
  • Ion Beam Applications SA
  • Isoray Medical, Inc.
  • Mevion Medical Systems, Inc.
  • Optivus Proton Therapy, Inc.
  • P-Cure Ltd.
  • Panacea Medical Technologies Pvt. Ltd.
  • Provision Healthcare, LLC.
  • Sumitomo Heavy Industries, Ltd
  • Theragenics Corporation
  • Varian Medical Systems, Inc.
  • Viewray Inc.
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4745162
Adroll
adroll